ZymoGenetics’ Atacicept Will Enter Phase II/III For Lupus Nephritis In Q4
This article was originally published in The Pink Sheet Daily
Executive Summary
Company and partner Merck Serono also are working with FDA to finalize protocol for study in general systemic lupus erythematosus.